BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27769358)

  • 21. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis.
    Dey A; Chitsaz F; Abbasi A; Misteli T; Ozato K
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8758-63. PubMed ID: 12840145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone acetylation and subcellular localization of chromosomal protein BRD4 during mouse oocyte meiosis and mitosis.
    Nagashima T; Maruyama T; Furuya M; Kajitani T; Uchida H; Masuda H; Ono M; Arase T; Ozato K; Yoshimura Y
    Mol Hum Reprod; 2007 Mar; 13(3):141-8. PubMed ID: 17267518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.
    Hewings DS; Wang M; Philpott M; Fedorov O; Uttarkar S; Filippakopoulos P; Picaud S; Vuppusetty C; Marsden B; Knapp S; Conway SJ; Heightman TD
    J Med Chem; 2011 Oct; 54(19):6761-70. PubMed ID: 21851057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding specificity and function of the SWI/SNF subunit SMARCA4 bromodomain interaction with acetylated histone H3K14.
    Enríquez P; Krajewski K; Strahl BD; Rothbart SB; Dowen RH; Rose RB
    J Biol Chem; 2021 Oct; 297(4):101145. PubMed ID: 34473995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A bromodomain-DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT.
    Miller TC; Simon B; Rybin V; Grötsch H; Curtet S; Khochbin S; Carlomagno T; Müller CW
    Nat Commun; 2016 Dec; 7():13855. PubMed ID: 27991587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical Proteomic Profiling of Bromodomains Enables the Wide-Spectrum Evaluation of Bromodomain Inhibitors in Living Cells.
    Li X; Wu Y; Tian G; Jiang Y; Liu Z; Meng X; Bao X; Feng L; Sun H; Deng H; Li XD
    J Am Chem Soc; 2019 Jul; 141(29):11497-11505. PubMed ID: 31246451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naphthyridines as novel BET family bromodomain inhibitors.
    Mirguet O; Lamotte Y; Chung CW; Bamborough P; Delannée D; Bouillot A; Gellibert F; Krysa G; Lewis A; Witherington J; Huet P; Dudit Y; Trottet L; Nicodeme E
    ChemMedChem; 2014 Mar; 9(3):580-9. PubMed ID: 24000170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermodynamic analysis of acetylation-dependent Pb1 bromodomain-histone H3 interactions.
    Thompson M; Chandrasekaran R
    Anal Biochem; 2008 Mar; 374(2):304-12. PubMed ID: 18191465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solution structure of human Brg1 bromodomain and its specific binding to acetylated histone tails.
    Shen W; Xu C; Huang W; Zhang J; Carlson JE; Tu X; Wu J; Shi Y
    Biochemistry; 2007 Feb; 46(8):2100-10. PubMed ID: 17274598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain.
    Evans CM; Phillips M; Malone KL; Tonelli M; Cornilescu G; Cornilescu C; Holton SJ; Gorjánácz M; Wang L; Carlson S; Gay JC; Nix JC; Demeler B; Markley JL; Glass KC
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BET bromodomain inhibitors show anti-papillomavirus activity in vitro and block CRPV wart growth in vivo.
    Morse MA; Balogh KK; Brendle SA; Campbell CA; Chen MX; Furze RC; Harada IL; Holyer ID; Kumar U; Lee K; Prinjha RK; Rüdiger M; Seal JT; Taylor S; Witherington J; Christensen ND
    Antiviral Res; 2018 Jun; 154():158-165. PubMed ID: 29653131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of chemical probes for the bromodomains of BRD7 and BRD9.
    Clark PG; Dixon DJ; Brennan PE
    Drug Discov Today Technol; 2016 Mar; 19():73-80. PubMed ID: 27769361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular delivery of acetyl-histone peptides inhibits native bromodomain-chromatin interactions and impairs mitotic progression.
    Nishiyama A; Mochizuki K; Mueller F; Karpova T; McNally JG; Ozato K
    FEBS Lett; 2008 Apr; 582(10):1501-7. PubMed ID: 18396160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of T
    Ghosh S; Lora JM
    Drug Discov Today Technol; 2016 Mar; 19():39-44. PubMed ID: 27769356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advancements in the Development of non-BET Bromodomain Chemical Probes.
    Clegg MA; Tomkinson NCO; Prinjha RK; Humphreys PG
    ChemMedChem; 2019 Feb; 14(4):362-385. PubMed ID: 30624862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.
    Chen J; Li Q
    Methods Mol Biol; 2013; 977():353-7. PubMed ID: 23436376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC inhibition results in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodies.
    Slaughter MJ; Shanle EK; Khan A; Chua KF; Hong T; Boxer LD; Allis CD; Josefowicz SZ; Garcia BA; Rothbart SB; Strahl BD; Davis IJ
    Cell Rep; 2021 Jan; 34(3):108638. PubMed ID: 33472068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding Mode of Acetylated Histones to Bromodomains: Variations on a Common Motif.
    Marchand JR; Caflisch A
    ChemMedChem; 2015 Aug; 10(8):1327-33. PubMed ID: 26033856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Gcn5 bromodomain co-ordinates nucleosome remodelling.
    Syntichaki P; Topalidou I; Thireos G
    Nature; 2000 Mar; 404(6776):414-7. PubMed ID: 10746732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bromodomain: from epigenome reader to druggable target.
    Sanchez R; Meslamani J; Zhou MM
    Biochim Biophys Acta; 2014 Aug; 1839(8):676-85. PubMed ID: 24686119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.